News
NEOGV
17.95
0.00%
0.00
Neogen beats Q3 revenue estimates, raises outlook
Reuters · 4h ago
Neogen Q3 FY26 net loss widens to $17 million; revenue drops 4.4% to $211.2 million
Reuters · 4h ago
CORRECTED-BRIEF-Neogen Q3 EPS USD -0.08
Reuters · 4h ago
NEOGEN REPORTS THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS
Reuters · 4h ago
Neogen names Jennifer Evans Stacey chief legal, compliance officer, board secretary
Reuters · 1d ago
NEOGEN® CORPORATION ANNOUNCES APPOINTMENT OF JENNIFER EVANS STACEY AS CHIEF LEGAL & COMPLIANCE OFFICER AND BOARD SECRETARY
Reuters · 1d ago
Neogen Chief Legal and Administrative Officer Amy Rocklin departs March 31
Reuters · 03/30 12:20
Neogen to report third-quarter fiscal 2026 results, host webcast and conference call
Reuters · 03/30 12:02
ZOETIS SHARES SLIP 1.4% ON DEAL TO BUY NEOGEN'S ANIMAL GENOMICS UNIT FOR $160 MILLION
Reuters · 03/02 14:31
BUZZ-U.S. STOCKS ON THE MOVE -Duolingo, AES, NextDecade
Reuters · 03/02 14:18
BUZZ-Zoetis slips on deal to buy Neogen's animal genomics unit for $160 million
Reuters · 03/02 12:17
Zoetis to Buy Neogen’s Animal Genomics Business for $160 Million
Reuters · 03/02 12:00
Neogen agrees to sell genomics unit to Zoetis for $160 million
Reuters · 03/02 12:00
NEOGEN CORP - PROCEEDS FROM SALE TO BE USED FOR DEBT REDUCTION
Reuters · 03/02 12:00
ZOETIS INC - TO BUY NEOGEN'S ANIMAL GENOMICS BUSINESS FOR $160 MLN
Reuters · 03/02 12:00
Neogen CEO Mikheal Nassif Acquires Common Shares
Reuters · 02/17 20:13
Neogen CEO Mikheal Nassif Reports Acquisition of Common Shares
Reuters · 02/02 21:36
NEOGEN CORP - RECALL DUE TO MICROBIAL CONTAMINATION IN CERTAIN VIALS
Reuters · 01/28 23:27
NEOGEN CORP - ADVERSE EVENTS REPORTED IN HORSES AFTER INTRAARTICULAR INJECTIONS
Reuters · 01/28 23:27
More
Webull provides a variety of real-time NEOGV stock news. You can receive the latest news about Neogen Corporation WI through multiple platforms. This information may help you make smarter investment decisions.
About NEOGV
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment is primarily engaged in the production and marketing of diagnostic test kits and complementary products marketed to food and feed producers and processors to detect dangerous and/or unintended substances in food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant byproducts, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market.